Evidence map›Paper›PMID 33705302›Full record

ReviewBiochemistry. Biokhimiia2020

Metabolic ROS Signaling: To Immunity and Beyond.

A Y Andreyev, Y E Kushnareva, N N Starkova, A A Starkov

Open access · bronzeAbstract readReview
In one paragraph

Review in Biochemistry. Biokhimiia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. The Pro-Metastatic Roles of ROS.Antioxidants (Basel, Switzerland) · 2026
    Review
  3. Review
  4. Toxic Effects of Acute Water Selenium Exposure onAnimals : an open access journal from MDPI · 2025
    Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Mechanisms of Oxidative Stress in Metabolic Syndrome.International journal of molecular sciences · 2023
    Review
  10. Article
  11. Article
  12. Review
  13. Unifying mechanism behind the onset of acquired epilepsy.Trends in pharmacological sciences · 2022
    Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

A Y AndreyevThe Scripps Research Institute, 10550 N Torrey Pines Rd, La Jolla, CA 92037, USA. alex_andreyev@mitoexperts.com.
Y E KushnarevaLa Jolla Institute for Allergy and Immunology, 9420 Athena Circle, La Jolla, CA 92037, USA. ykushnareva@sbpdiscovery.org.
N N StarkovaState University of New York, Maritime College, New York, NY 10465, USA. nstarkova@sunymaritime.edu.
A A StarkovBrain and Mind Research Institute, Weill Medical College of Cornell University, New York, NY 10065, USA. ans2024@med.cornell.edu.
Cornell University · USLa Jolla Institute for Immunology · USScripps Research Institute · USSUNY Maritime College · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metabolism is a critical determinant of immune cell functionality. Immunometabolism, by definition, is a multidisciplinary area of immunology research that integrates the knowledge of energy transduction mechanisms and biochemical pathways. An important concept in the field is metabolic switch, a transition of immune cells upon activation to preferential utilization of select catabolic pathways for their energy needs. Mitochondria are not inert in this process and contribute to the metabolic adaptation by different mechanisms which include increasing ATP production to match dynamic bioenergetic demands and serving as a signaling platform. The latter involves generation of reactive oxygen species (ROS), one of the most intensively studied mitochondrial processes. While the role of mitochondrial ROS in the context of oxidative stress is well established, ROS signaling in immunity is an emerging and quickly changing field. In this review, we discuss ROS signaling and immunometabolism concepts from the standpoint of bioenergetics. We also provide a critical insight into the methodology for ROS assessment, outlining current challenges in the field. Finally, based on our analysis of the literature data, we hypothesize that regulatory ROS production, as opposed to oxidative stress, is controlled by mitochondrial biogenesis rather than metabolic switches.

Indexed as

Energy MetabolismSignal TransductionAnimalsHumansImmune SystemMitochondriaOxidative StressReactive Oxygen SpeciesReactive Oxygen Species

Identifiers

PMID33705302
PMCPMC7768995
OpenAlexW3115948567

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.